Fundraising Fox

Dravite Therapeutics

San Francisco, US · Founded 2025 · Delaware corporation

Founders & leadership

MM
MICHAEL MOOREinExecutive
MM
MATTHEW MOORENamed on SEC filing
JG
JEREMY GOLDBERGNamed on SEC filing
RG
RISHI GUPTANamed on SEC filing

Board

JS
JOSEPH SUMBoard director
SK
SANDEEP KULKARNIBoard director
BK
BARBARA KOSACZBoard director

Reported raises · per SEC filings

Form D private placements

$68M disclosed across 2 rounds · 2026

▶$53MraisedSep 2026 · 11 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • JOSEPH SUMExecutive Officer, Director
  • SANDEEP KULKARNIDirector
  • BARBARA KOSACZDirector
  • MATTHEW MOOREExecutive Officer, Director
  • JEREMY GOLDBERGDirector
  • RISHI GUPTADirector
Offering amount
$53M
Amount sold
$53M
First sale
Aug 2026
Incorporated
Corporation, Delaware, 2025
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15MraisedJul 2026 · 8 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • JOSEPH SUMDirector
  • SANDEEP KULKARNIDirector
  • BARBARA KOSACZDirector
  • MATTHEW MOOREExecutive Officer, Director
Offering amount
$15M
Amount sold
$15M
First sale
Apr 2026
Incorporated
Corporation, Delaware, 2025
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Dravite Therapeutics raised?
Dravite Therapeutics has disclosed $68M raised across 2 rounds.
Where is Dravite Therapeutics headquartered?
Dravite Therapeutics is headquartered in San Francisco, US.